When can I safely restart methotrexate and adalimumab after infection‑related diarrhea with bandemia while being treated with oral cephalexin (Keflex)?

When to Restart Methotrexate and Adalimumab After Infection

You should restart methotrexate and adalimumab 14 days after complete resolution of your infection symptoms (diarrhea and bandemia), provided you have completed your full course of oral cephalexin and have no fever or ongoing signs of infection.

Clinical Reasoning

The presence of bandemia with diarrhea indicates an active bacterial infection with significant inflammatory response. Bandemia (elevated immature neutrophils) suggests your bone marrow is actively responding to infection, which is a marker of moderate-to-severe bacterial illness 1. This creates a critical window where immunosuppression must be avoided.

Key Timing Considerations

Complete antibiotic course first:

• Finish your full course of oral cephalexin (Keflex) as prescribed
• Do not restart immunosuppression while still on active antibiotic therapy for acute infection 2

Wait for symptom resolution:

• Diarrhea must be completely resolved
• No fever for at least 14 days
• Bandemia should normalize (requires repeat CBC to confirm)
• No signs of ongoing infection (abdominal pain, systemic symptoms)

The 14-day rule: British Society of Gastroenterology guidance specifically states that after testing positive for infection or developing symptoms, immunomodulators (methotrexate) and biologics should be stopped, and "14 days after your symptoms have resolved...contact your local IBD team for advice regarding restarting your medication" 3. This applies to your situation with bacterial infection causing diarrhea.

Specific Restart Protocol

Before Restarting:

1. Confirm infection clearance:

   • No diarrhea for 14 consecutive days
   • No fever
   • Repeat CBC showing resolution of bandemia
   • Clinical improvement in overall condition

2. Laboratory monitoring:

   • Check CBC, liver function tests, and renal function before restarting 4
   • Ensure albumin has normalized (hypoalbuminemia with bandemia predicts poor outcomes) 1

3. Contact your IBD/rheumatology team:

   • Do not restart on your own
   • Physician assessment is mandatory before resuming immunosuppression 3

Restart Sequence:

Start methotrexate first, then adalimumab:

• Methotrexate has a shorter half-life (3-10 hours) and can be restarted first 5
• Wait 1 week after restarting methotrexate before resuming adalimumab
• This staged approach allows monitoring for any recurrent infection signs

Critical Warnings

Do NOT restart if:

• Still having any diarrhea
• Any fever present
• Bandemia persists on repeat labs
• Less than 14 days since symptom resolution
• Still on antibiotics for the acute infection

Why this matters for mortality/morbidity:

• Restarting immunosuppression too early during active infection significantly increases risk of sepsis and severe complications 3
• The combination of methotrexate and adalimumab creates substantial immunosuppression, increasing infection risk 2.4-fold 6, 7
• Bandemia specifically indicates ongoing bacterial infection that could become life-threatening if immunosuppression is resumed prematurely 1

Common Pitfalls to Avoid

1. Don't assume symptom improvement means infection is cleared - wait the full 14 days after complete resolution
2. Don't restart both medications simultaneously - stage the restart with methotrexate first
3. Don't skip the repeat CBC - you need objective confirmation that bandemia has resolved
4. Don't restart without physician contact - this is explicitly recommended in guidelines 3

The immunosuppressive effects of these medications persist for weeks after stopping 3, so there's no urgency to restart immediately. Prioritizing complete infection clearance over disease control in this acute setting is essential for preventing life-threatening complications.